Literature DB >> 29438039

Blood-ocular barrier disruption in patients with acute stroke.

Emi Hitomi1, Alexis N Simpkins1, Marie Luby1, Lawrence L Latour1, R John Leigh1, Richard Leigh2.   

Abstract

OBJECTIVE: Prompted by the unexpected finding of gadolinium leakage into ocular structures (GLOS) in acute stroke patients, we studied the frequency and nature of this finding in 167 patients.
METHODS: Patients were selected who had an MRI with gadolinium at baseline and another MRI with fluid-attenuated inversion recovery (FLAIR) imaging at 2 and/or 24 hours later. GLOS was detected as lack of vitreous and/or aqueous fluid suppression on postcontrast FLAIR images.
RESULTS: GLOS, evident on postcontrast FLAIR MRI, occurred in 127/167 (76%) patients: 86/109 (79%) patients treated with tissue plasminogen activator and 41/58 (71%) who were untreated. At 2 hours after administration of the contrast, GLOS was more common in the aqueous chamber alone, occurring in 67% of patients, compared to the vitreous chamber alone, seen in 6% of patients; it occurred in both chambers in 27% of patients. At 24 hours, GLOS was present in 121/162 (75%) patients, always involving the vitreous chamber, but also affecting the aqueous chamber in 6% of cases. Vitreous GLOS at 24 hours was associated with increasing age (p = 0.002) and a higher burden of cerebral white matter hyperintensities (p = 0.017). Patients with rapid diffuse GLOS, defined as GLOS involving both chambers at 2 hours, had larger infarcts (p = 0.022) and a higher degree of blood-brain barrier permeability (p = 0.025).
CONCLUSIONS: We found GLOS to be common in patients with acute stroke; delayed GLOS was a marker for chronic vascular disease. The mechanism for acute GLOS remains uncertain but may be a remote effect of acute cerebral injury on the blood-ocular barrier.
© 2018 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29438039      PMCID: PMC5858944          DOI: 10.1212/WNL.0000000000005123

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

Review 1.  Blood-brain barrier breakdown in acute and chronic cerebrovascular disease.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Stroke       Date:  2011-09-22       Impact factor: 7.914

2.  Ocular hyperintense acute reperfusion marker.

Authors:  Johanna Hamel; Jochen B Fiebach; Kersten Villringer
Journal:  Neurology       Date:  2012-09-26       Impact factor: 9.910

Review 3.  Integration of tight junctions and claudins with the barrier functions of the retinal pigment epithelium.

Authors:  Lawrence J Rizzolo; Shaomin Peng; Yan Luo; Wei Xiao
Journal:  Prog Retin Eye Res       Date:  2011-06-17       Impact factor: 21.198

4.  Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.

Authors:  Alexis N Simpkins; Christian Dias; Richard Leigh
Journal:  Stroke       Date:  2016-07-26       Impact factor: 7.914

5.  Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption.

Authors:  Steven Warach; Lawrence L Latour
Journal:  Stroke       Date:  2004-10-07       Impact factor: 7.914

6.  Cerebral white matter lesions, retinopathy, and incident clinical stroke.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; David J Couper; Barbara E K Klein; Duan-Ping Liao; Larry D Hubbard; Thomas H Mosley
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

7.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

8.  Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator.

Authors:  Richard Leigh; Shyian S Jen; Argye E Hillis; John W Krakauer; Peter B Barker
Journal:  Stroke       Date:  2014-05-15       Impact factor: 7.914

9.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

10.  Arrival time correction for dynamic susceptibility contrast MR permeability imaging in stroke patients.

Authors:  Richard Leigh; Shyian S Jen; Daniel D Varma; Argye E Hillis; Peter B Barker
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more
  7 in total

1.  Usefulness of diffusion-weighted MRI in the initial assessment of osseous sarcomas in children and adolescents.

Authors:  Alaa N Alsharief; Claudia Martinez-Rios; Sevan Hopyan; Afsaneh Amirabadi; Andrea S Doria; Mary-Louise C Greer
Journal:  Pediatr Radiol       Date:  2019-06-15

2.  Quantitative imaging of the clearance systems in the eye and the brain.

Authors:  Wenyu Deng; Crystal Liu; Carlos Parra; Jeffrey R Sims; Muneeb A Faiq; Anoop Sainulabdeen; Hana Song; Kevin C Chan
Journal:  Quant Imaging Med Surg       Date:  2020-01

3.  Glymphatic System in Ocular Diseases: Evaluation of MRI Findings.

Authors:  P Manava; C Eckrich; F Luciani; J Schmidbauer; M M Lell; K Detmar
Journal:  AJNR Am J Neuroradiol       Date:  2022-06-30       Impact factor: 4.966

4.  The anterior eye chamber: entry of the natural excretion pathway of gadolinium contrast agents?

Authors:  Katerina Deike-Hofmann; Paula von Lampe; Heinz-Peter Schlemmer; Nikolaos Bechrakis; Christoph Kleinschnitz; Michael Forsting; Alexander Radbruch
Journal:  Eur Radiol       Date:  2020-03-16       Impact factor: 5.315

Review 5.  Role of Structural, Metabolic, and Functional MRI in Monitoring Visual System Impairment and Recovery.

Authors:  Jeffrey R Sims; Anna M Chen; Zhe Sun; Wenyu Deng; Nicole A Colwell; Max K Colbert; Jingyuan Zhu; Anoop Sainulabdeen; Muneeb A Faiq; Ji Won Bang; Kevin C Chan
Journal:  J Magn Reson Imaging       Date:  2020-10-02       Impact factor: 4.813

6.  Distribution of Gadolinium-based Contrast Agent after Leaking into the Cerebrospinal Fluid: Comparison between the Cerebral Cisterns and the Lateral Ventricles.

Authors:  Toshio Ohashi; Shinji Naganawa; Saeko Iwata; Kayao Kuno
Journal:  Magn Reson Med Sci       Date:  2020-07-09       Impact factor: 2.471

7.  Vascular Interventional Radiology-Guided Photothermal Therapy of Colorectal Cancer Liver Metastasis with Theranostic Gold Nanorods.

Authors:  Abdul Kareem Parchur; Gayatri Sharma; Jaidip M Jagtap; Venkateswara Rao Gogineni; Peter S LaViolette; Michael J Flister; Sarah Beth White; Amit Joshi
Journal:  ACS Nano       Date:  2018-07-06       Impact factor: 18.027

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.